期刊文献+

HPLC法测去甲氧基姜黄素纳米脂质载体中药物的含量 被引量:1

Content determination of by ultraviolet spectrophotometry
下载PDF
导出
摘要 目的:建立HPLC法测去甲氧基姜黄素纳米粒脂质载体(NLC)中药物含量的方法。方法:采用HPLC法测定纳米脂质载体(NLC)中药物的含量。结果表明去甲氧基姜黄素在420nm处有最大吸收,浓度在2.04至52.5mg·mL-1时与吸光度呈良好的线性关系,回归方程为:Y=121.29C X-296.19,r=0.9997(n=6);平均回收率为99.19%,RSD为0.79%。结论:本方法操作简单,且稳定性、准确度和精密度均符合要求,可用于NLC制剂中去甲氧基姜黄素含量的测定。 Objective: To establish the method determination of deme-thoxycurcumin from NLC. Method: HPLC assay was used, 1=420 nm. Result: It had good linearity with the 2.04-52.5mg · mL-1 concentration range of deme-thoxycurcumin . The re- gression is Y =121.29C X -296.19, r =0.9997( n =6) The recovery from the sample was 99.19%, RSD 为 0.79%.Conclusion: This method is could used to quality standards for deme-thoxycurcumin of NLC.
出处 《激光杂志》 CAS CSCD 北大核心 2014年第1期56-57,共2页 Laser Journal
基金 重庆市教育委员会资助项目(KJ120321)
关键词 去甲氧基姜黄素 纳米脂质载体 HPLC法 含量测定 Deme-thoxycurcumin lipid nanoparticles concent
  • 相关文献

参考文献6

二级参考文献18

共引文献18

同被引文献18

  • 1国家药典委员会.中国药典2010年版二部[M].北京:中国医药科技出版社,2010:25.
  • 2Zhu H T, Bian C, Yuan J C, et al. Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF- KB signaling pathway in experimental traumatic brain injury [J]. J Neuroinflammation. 2014, 11: 59.
  • 3Wongeakin N, Bhattarakosol P, Patumraj S. Molecular mech- anisms of curcumin on diabetes-induced endothelial dysfunc- tions : Txnip, ICAM-1, and NOX2 expressions [ J ]. BiomedRes Int, 2014, 2014: 161346.
  • 4Xie Y, Zhao Q Y, Li H Y, et al. Curcumin ameliorates cogni- tive deficits heavy ion irradiation-induced learning and memory deficits t|u'ough enhancing of Nr2 antioxidant signaling pathways [J]. Pharmaeol Biochem Behav, 2014, 126:181-186.
  • 5Glombik K, Basta-Kaim A, Sikora-Polaczek M, et al. Curcu- min influences semen quality parameters and reverses the di (2-ethylhexyl) phthalate (DEHP)-induced testicular damage in mice[J]. Pharmacol Rep, 2014, 66(5) : 782 -787.
  • 6Tan Q, Wu J, Li Y, et al. A supermolecular curcumin for enhanced antiproliferative and proapoptotic activities: molecu- lar characteristics, computer modeling and in vivo pharmaco- kinetics[ J ]. Nanotechnology, 2013, 24 (3) : 035102.
  • 7郭曼曼,管佳妮,王国伟,等.姜黄素PEG-PCL纳米粒的制备及药动学和体外抑瘤作用研究[c]//抗肿瘤药物研究新进展与肿瘤个性化药物治疗论坛论文集,杭州:浙江省抗癌协会,2013.
  • 8曾晓会,陈玉兴,赵自明,黄雪君,杜铁良.姜黄素微囊在大鼠体内的药代动力学研究[J].中国实验方剂学杂志,2010,16(2):107-110. 被引量:18
  • 9张立康,汪小珍,李婉姝,邱相君,孙未,胡国新.姜黄素在大鼠体内药代动力学和生物利用度研究[J].中国药理学通报,2011,27(10):1458-1462. 被引量:56
  • 10陈曦,肖衍宇,陈祎楠,平其能,张灿.姜黄素纳米脂质载体的制备及大鼠体内药代动力学[J].中国药科大学学报,2012,43(5):412-417. 被引量:11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部